Description
An HIV protease inhibitor; inhibits recombinant HIV-1 protease by 79% at 0.5 nM; inhibits HIV-13B-induced cell death in MT-4 human T cell leukemia cells (EC50 = 25 nM); inhibits cell death induced by HIV-1LAI, HIV-2ROD, and HIV-2EHO in human MT-2 cells (IC50s = 0.045, 0.13, and 0.24 μM, respectively); inhibits the CYP isoform CYP3A (IC50 = 0.14 μM); inhibits CYP-mediated oxidative metabolism of saquinavir, indinavir, nelfinavir, and amprenavir in rat and human liver microsomes; prevents decreases in plasma levels of these four compounds in rats at 10 mg/kg
Formal name: (3S,4S,6S,9S)-4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic acid, 5-thiazolylmethyl ester
Synonyms: A-84538|ABT-538|NSC 693184|RTV
Molecular weight: 720.9
CAS: 155213-67-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|Protease Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|HIV & AIDS